Targeted overexpression of leukemia inhibitory factor to preserve myocardium in a rat model of postinfarction heart failure
- PMID: 15573071
- DOI: 10.1016/j.jtcvs.2004.06.046
Targeted overexpression of leukemia inhibitory factor to preserve myocardium in a rat model of postinfarction heart failure
Abstract
Objective: Myocardial infarction leads to cardiomyocyte loss. The cytokine leukemia inhibitory factor regulates the differentiation and growth of embryonic and adult heart tissue. This study examined the effects of gene transfer of leukemia inhibitory factor in infarcted rat hearts.
Methods: Lewis rats underwent ligation of the left anterior descending coronary artery and direct injection of adenovirus encoding leukemia inhibitory factor (n = 10) or null transgene as control (n = 10) into the myocardium bordering the ischemic area. A sham operation group (n = 10) underwent thoracotomy without ligation. After 6 weeks, the following parameters were evaluated: cardiac function with a pressure-volume conductance catheter, left ventricular geometry and architecture by histologic methods; myocardial fibrosis by Masson trichrome staining, apoptosis by terminal deoxynucleotidal transferase-mediated deoxyuridine triphosphate nick-end labeling assay, and cardiomyocyte size by immunofluorescence.
Results: Rats with overexpression of leukemia inhibitory factor had more preserved myocardium and less fibrosis in both the infarct and its border zone. The border zone in leukemia inhibitory factor-treated animals contained fewer apoptotic nuclei (1.6% +/- 0.1% vs 3.3% +/- 0.2%, P < .05) than that in control animals and demonstrated cardiomyocytes with larger cross-sectional areas (910 +/- 60 microm 2 vs 480 +/- 30 microm 2 , P < .05). Leukemia inhibitory factor-treated animals had increased left ventricular wall thickness (2.1 +/- 0.1 mm vs 1.8 +/- 0.1 mm, P < .05) and less dilation of the left ventricular cavity (237 +/- 22 microL vs 301 +/- 16 microL, P < .05). They also had improved cardiac function, as measured by maximum change in pressure over time (3950 +/- 360 mm Hg/s vs 2750 +/- 230 mm Hg/s, P < .05) and the slopes of the maximum change in pressure over time-end-diastolic volume relationship (68 +/- 5 mm Hg/[s . microL] vs 46 +/- 6 mm Hg/[s . microL], P < .05) and the preload recruitable stroke work relationship (89 +/- 10 mm Hg vs 44 +/- 4 mm Hg, P < .05).
Conclusions: Myocardial gene transfer of leukemia inhibitory factor preserved cardiac tissue, geometry, and function after myocardial infarction in rats.
Similar articles
-
Local myocardial overexpression of growth hormone attenuates postinfarction remodeling and preserves cardiac function.Ann Thorac Surg. 2004 Jun;77(6):2122-9; discussion 2129. doi: 10.1016/j.athoracsur.2003.12.043. Ann Thorac Surg. 2004. PMID: 15172279
-
Gene transfer of hepatocyte growth factor attenuates postinfarction heart failure.Circulation. 2003 Sep 9;108 Suppl 1:II230-6. doi: 10.1161/01.cir.0000087444.53354.66. Circulation. 2003. PMID: 12970238
-
Targeted overexpression of growth hormone by adenoviral gene transfer preserves myocardial function and ventricular geometry in ischemic cardiomyopathy.J Mol Cell Cardiol. 2004 Apr;36(4):531-8. doi: 10.1016/j.yjmcc.2004.01.010. J Mol Cell Cardiol. 2004. PMID: 15081312
-
Induction of angiogenesis and inhibition of apoptosis by hepatocyte growth factor effectively treats postischemic heart failure.J Card Surg. 2005 Jan-Feb;20(1):93-101. doi: 10.1111/j.0886-0440.2005.200373.x. J Card Surg. 2005. PMID: 15673421
-
Effects of acute ventricular volume manipulation on in situ cardiomyocyte cell membrane configuration.Prog Biophys Mol Biol. 2003 May-Jul;82(1-3):221-7. doi: 10.1016/s0079-6107(03)00024-5. Prog Biophys Mol Biol. 2003. PMID: 12732281 Review.
Cited by
-
Gene therapy for ischemic heart disease.J Mol Cell Cardiol. 2011 May;50(5):742-50. doi: 10.1016/j.yjmcc.2010.06.007. Epub 2010 Jun 26. J Mol Cell Cardiol. 2011. PMID: 20600100 Free PMC article. Review.
-
Heart failure causes cholinergic transdifferentiation of cardiac sympathetic nerves via gp130-signaling cytokines in rodents.J Clin Invest. 2010 Feb;120(2):408-21. doi: 10.1172/JCI39778. Epub 2010 Jan 4. J Clin Invest. 2010. PMID: 20051627 Free PMC article.
-
JAK redux: a second look at the regulation and role of JAKs in the heart.Am J Physiol Heart Circ Physiol. 2009 Nov;297(5):H1545-56. doi: 10.1152/ajpheart.00032.2009. Epub 2009 Aug 28. Am J Physiol Heart Circ Physiol. 2009. PMID: 19717737 Free PMC article. Review.
-
Investigation into the effects of leukemia inhibitory factor on the bone repair capacity of BMSCs-loaded BCP scaffolds in the mouse calvarial bone defect model.J Bioenerg Biomembr. 2021 Aug;53(4):381-391. doi: 10.1007/s10863-021-09899-z. Epub 2021 Jun 10. J Bioenerg Biomembr. 2021. PMID: 34110599
-
The relationship between inflammatory factors and heart failure: evidence based on bidirectional Mendelian randomization analysis.Front Cardiovasc Med. 2024 Dec 12;11:1378327. doi: 10.3389/fcvm.2024.1378327. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39726944 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources